• Alnylam Pharmaceuticals average current ratio for 2023 was 3.3, a 12.23% decline from 2022.
• Alnylam Pharmaceuticals average current ratio for 2022 was 3.76, a 17.9% decline from 2021.
• Alnylam Pharmaceuticals average current ratio for 2021 was 4.58, a 8.95% decline from 2020.

Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.